Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cell Death & Disease|August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomasSonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
British Journal of Cancer|June 28, 2024
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumoursTill Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survivalAurélie Ernst, Stefanie Hofmann, Rezvan Ahmadi, et al.
Cancer Research|December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid TumorsDina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
NPJ Precision Oncology|June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncologyAnna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
Brain : a Journal of Neurology|March 20, 2012
KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomasAntje Brockschmidt, Detlef Trost, Heike Peterziel, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Iscience|January 26, 2026
Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastomaAnna S Kolodziejczak, Florian Selt, Heike Peterziel, et al.
Neuro-Oncology|July 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma modelsRomain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.
Neuro-Oncology|August 17, 2022
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytomaFlorian Selt, Romain Sigaud, Gintvile Valinciute, et al.
Pageof 5